Premium
AMPK does not play a requisite role in regulation of PPARGC1A gene expression via the alternative promoter in endurance‐trained human skeletal muscle
Author(s) -
Popov Daniil V.,
Lysenko Evgeny A.,
Butkov Alexey D.,
Vepkhvadze Tatiana F.,
Perfilov Dmitriy V.,
Vinogradova Olga L.
Publication year - 2017
Publication title -
experimental physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.925
H-Index - 101
eISSN - 1469-445X
pISSN - 0958-0670
DOI - 10.1113/ep086074
Subject(s) - ampk , skeletal muscle , ppargc1a , gene expression , gene , microbiology and biotechnology , biology , endocrinology , genetics , transcription factor , phosphorylation , protein kinase a , coactivator
New FindingsWhat is the central question of this study? This study was designed to investigate the role of AMPK in the regulation of PGC‐1α gene expression via the alternative promoter through a cAMP response element‐binding protein‐1‐dependent mechanism in human skeletal muscle.What is the main finding and its importance? Low‐intensity exercise markedly increased the expression of PGC‐1α mRNA via the alternative promoter, without increases in ACC Ser79/222 (a marker of AMPK activation) and AMPK Thr172 phosphorylation. A single dose of the AMPK activator metformin indicated that AMPK was not involved in regulating PGC‐1α mRNA expression via the alternative promoter in endurance‐trained human skeletal muscle.In human skeletal muscle, PGC‐1α is constitutively expressed via the canonical promoter. In contrast, the expression of PGC‐1α mRNA via the alternative promoter was found to be highly dependent on the intensity of exercise and to contribute largely to the postexercise increase of total PGC‐1α mRNA. This study investigated the role of AMPK in regulating PGC‐1α gene expression via the alternative promoter through a cAMP response element‐binding protein‐1‐dependent mechanism in human skeletal muscle. AMPK activation and PGC‐1α gene expression were assayed in skeletal muscle of nine endurance‐trained men before and after low‐intensity exercise (38% of maximal oxygen uptake) and with or without administration of a single dose (2 g) of the AMPK activator metformin. Low‐intensity exercise markedly and significantly increased (∼100‐fold, P < 0.05) the expression of PGC‐1α mRNA via the alternative promoter, without increasing ACC Ser79/222 (a marker of AMPK activation) and AMPK Thr172 phosphorylation. Moreover, in contrast to placebo, metformin increased the level of ACC Ser79/222 phosphorylation immediately after exercise (2.6‐fold, P < 0.05). However postexercise expression of PGC‐1α gene via the alternative promoter was not affected. This study was unable to confirm that AMPK plays a role in regulating PGC‐1α gene expression via the alternative promoter in endurance‐trained human skeletal muscle.